Skip to content

Effects of Apelin-13 on severity and prognosis of septic associated acute lung injury

Effects of Apelin-13 on severity and prognosis of septic associated acute lung injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054712
Enrollment
Unknown
Registered
2021-12-24
Start date
2021-12-24
Completion date
Unknown
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sepsis-related acute lung injury group :no intervention

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Sepsis-related acute lung injury group: 1. Aged >= 18 years; 2. According to the guidelines for the treatment of sepsis in my country (2018 edition), patients with a definite diagnosis of sepsis (for patients with infection or suspected infection, when the SOFA score of sepsis-related sequential organ failure rises >= 2 points from the baseline can be diagnosed as sepsis); according to the Berlin definition (2012 edition), a definite diagnosis of ARDS (acute onset; hypoxemia, oxygenation index = 18 years; 2. No evidence of acute infection; 3. I or my guardian signed the informed consent form agreeing to participate in this research.

Exclusion criteria

Exclusion criteria: 1. Sepsis-related acute lung injury group: combined with other serious systemic diseases; 2. Normal control group: combined with other serious systemic diseases.

Design outcomes

Primary

MeasureTime frame
Apelin-13;

Countries

China

Contacts

Public ContactMeng Ying

Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University

519343749@qq.com+86 13631366052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026